Literature DB >> 22127360

Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT).

Marlies Pasler1, Holger Wirtz, Johannes Lutterbach.   

Abstract

BACKGROUND AND
PURPOSE: To compare plan quality criteria and dosimetric accuracy of step-and-shoot intensity-modulated radiotherapy (ss-IMRT) and volumetric modulated arc radiotherapy (VMAT) using two different gantry rotation times. PATIENTS AND METHODS: This retrospective planning study based on 20 patients was comprised of 10 prostate cancer (PC) and 10 head and neck (HN) cancer cases. Each plan contained two target volumes: a primary planning target volume (PTV) and a boost volume. For each patient, one ss-IMRT plan and two VMAT plans at 90 s (VMAT90) and 120 s (VMAT120) per arc were generated with the Pinnacle© planning system. Two arcs were provided for the PTV plans and a single arc for boost volumes. Dosimetric verification of the plans was performed using a 2D ionization chamber array placed in a full scatter phantom.
RESULTS: VMAT reduced delivery time and monitor units for both treatment sites compared to IMRT. VMAT120 vs. VMAT90 increased delivery time and monitor units in PC plans without improving plan quality. For HN cases, VMAT120 provided comparable organs at risk sparing and better target coverage and conformity than VMAT90. In the VMAT plan verification, an average of 97.1% of the detector points passed the 3 mm, 3% γ criterion, while in IMRT verification it was 98.8%.
CONCLUSION: VMAT90, VMAT120, and IMRT achieved comparable treatment plans. Slower gantry movement in VMAT120 plans only improves dosimetric quality for highly complex targets.

Entities:  

Mesh:

Year:  2011        PMID: 22127360     DOI: 10.1007/s00066-011-2263-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

Review 1.  Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.

Authors:  V Grégoire; E Coche; G Cosnard; M Hamoir; H Reychler
Journal:  Radiother Oncol       Date:  2000-08       Impact factor: 6.280

Review 2.  Intensity-modulated radiotherapy: current status and issues of interest.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-15       Impact factor: 7.038

3.  Segment-based dose optimization using a genetic algorithm.

Authors:  Cristian Cotrutz; Lei Xing
Journal:  Phys Med Biol       Date:  2003-09-21       Impact factor: 3.609

4.  Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.

Authors:  Tilo Wiezorek; Nico Banz; Michael Schwedas; Marcel Scheithauer; Henning Salz; Dietmar Georg; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2005-07       Impact factor: 3.621

5.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

6.  Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arc.

Authors:  Judith Alvarez Moret; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

7.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

Review 8.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

9.  Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.

Authors:  Wilko F A R Verbakel; Johan P Cuijpers; Daan Hoffmans; Michael Bieker; Ben J Slotman; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-01       Impact factor: 7.038

10.  Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.

Authors:  Pengpeng Zhang; Laura Happersett; Margie Hunt; Andrew Jackson; Michael Zelefsky; Gig Mageras
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-18       Impact factor: 7.038

View more
  17 in total

1.  New possibilities for volumetric-modulated arc therapy using the Agility™ 160-leaf multileaf collimator.

Authors:  Nadine Blümer; Christian Scherf; Janett Köhn; Eugen Kara; Britta Loutfi-Krauß; Detlef Imhoff; Claus Rödel; Ulla Ramm; Jörg Licher
Journal:  Strahlenther Onkol       Date:  2014-07-25       Impact factor: 3.621

2.  Influence of metallic dental implants and metal artefacts on dose calculation accuracy.

Authors:  Manuel Maerz; Oliver Koelbl; Barbara Dobler
Journal:  Strahlenther Onkol       Date:  2014-10-31       Impact factor: 3.621

3.  Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer.

Authors:  R Cambria; F Cattani; B A Jereczek-Fossa; F Pansini; D Ciardo; S Vigorito; S Russo; D Zerini; L Cozzi; R Orecchia
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

4.  Patient-related quality assurance with different combinations of treatment planning systems, techniques, and machines : A multi-institutional survey.

Authors:  Beatrice Steiniger; René Berger; Sabine Eilzer; Christine Kornhuber; Kathleen Lorenz; Torsten Peil; Carsten Reiffenstuhl; Johannes Schilz; Dirk Schröder; Michael Schwedas; Stephanie Pensold; Mathias Walke; Kirsten Weibert; Ulrich Wolf; Tilo Wiezorek
Journal:  Strahlenther Onkol       Date:  2016-11-03       Impact factor: 3.621

5.  Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

Authors:  E K Uzel; S Karaçam; O Eliçin; O Uzel
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

6.  Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcome.

Authors:  K Vandecasteele; A Makar; R Van den Broecke; L Delrue; H Denys; K Lambein; B Lambert; M van Eijkeren; P Tummers; G De Meerleer
Journal:  Strahlenther Onkol       Date:  2012-04-19       Impact factor: 3.621

7.  Node-positive left-sided breast cancer: does VMAT improve treatment plan quality with respect to IMRT?

Authors:  M Pasler; D Georg; S Bartelt; J Lutterbach
Journal:  Strahlenther Onkol       Date:  2013-03-24       Impact factor: 3.621

8.  Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer.

Authors:  Stéphanie Smet; Maarten Lambrecht; Bianca Vanstraelen; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2014-08-29       Impact factor: 3.621

9.  Dosimetric effect of limited aperture multileaf collimator on VMAT plan quality: A study of prostate and head-and-neck cancers.

Authors:  Ghulam Murtaza; Shahid Mehmood; Shahid Rasul; Imran Murtaza; Ehsan Ullah Khan
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-21

10.  Evaluation of a new foetal shielding device for pregnant brain tumour patients.

Authors:  Seonghee Kang; Kyeong-Hyeon Kim; Sang-Won Kang; Dong-Seok Shin; Seungwan Lee; Jin-Beom Chung
Journal:  Radiat Oncol       Date:  2021-06-13       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.